Patients who experience a nonaneurysmal subarachnoid hemorrhage differ from patients who suffer an aneurysmal subarachnoid hemorrhage in initial presentation (including neurological examination and ...

Use of GLP-1s is linked to lower risk for subarachnoid hemorrhage and mortality in patients with intracranial aneurysms and type 2 diabetes compared to use of other agents, a new study shows.

Aneurysmal subarachnoid hemorrhage-related hydrocephalus (aSAH-H) is a clinical syndrome that leads to excessive accumulation of cerebrospinal fluid (CSF) and ventricle enlargement in the brain.

Subarachnoid hemorrhages, which are caused by ruptured brain aneurysms, account for 5-10 percent of all strokes and are best managed by experienced and dedicated experts at high-volume centers with ...

Subarachnoid haemorrhage (SAH), the most fatal of all cerebrovascular disturbances, results in death for 40-50% of patients suffering from the condition in the first months after the haemorrhage. The ...

Subarachnoid hemorrhage is a type of bleeding stroke which can lead to a delayed ischemic stroke after just a few days. Researchers from Charité – Universitätsmedizin Berlin have shown that massive ...

Please provide your email address to receive an email when new articles are posted on . Machine learning models significantly outperformed standard models in predicting delayed cerebral ischemia and ...

Please provide your email address to receive an email when new articles are posted on . EARLYDRAIN trial included 287 adults randomly assigned to receive lumbar drainage with standard care or standard ...

A large population-based study found that statin use was significantly associated with a reduced risk of SAH. Research suggested potential clinical benefit to statins in this setting, particularly in ...

Globally, 1 in 4 people over 25 will have a stroke of some form, according to the World Stroke Organization. Subarachnoid hemorrhages account for approximately 1.2 million cases of stroke each year, ...